Cohen Ben, Cohen Sharon, Tor Ruth, Shochat Tzippy, Fuchs Shmuel, Kornowski Ran, Grossman Alon, Hasdai David
Cardiology Department, Rabin Medical Center, Petah Tikva, 4941492,Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, 6905904, Israel.
Eur Heart J Qual Care Clin Outcomes. 2023 Apr 26;9(3):207-215. doi: 10.1093/ehjqcco/qcad003.
Many patients with suspected non-ST-elevation (NSTE) acute coronary syndromes (ACS) are admitted, even those with initial high-sensitivity cardiac troponins (hs-cTn) values who meet rapid rule-out criteria for myocardial infarction (MI). We examined the clinical outcomes, resource utilization, and diagnostic yield of suspected NSTE-ACS patients, who presented with hs-cTnT values meeting these criteria but were nevertheless hospitalized.
Applying the 2020 European Society of Cardiology (ESC) rapid rule-out MI criteria, we identified consecutive patients with an initial value of hs-cTnT <5 ng/L or an initial value of ≥5 ng/L but <14 ng/L (99th percentile) and a small increment in a subsequent test, who were nevertheless admitted. The majority (85.4%) of patients presented to the emergency department (ED) with suspected NSTE-ACS had an initial hs-cTnT <99th percentile. We examined 3775 admitted patients out of 11 477 patients who were triaged and met MI rule-out criteria. Only 0.32% (12 patients) of admitted patients experienced index MI or overall death within 30 days. Resource utilization in terms of ED stay, hospital stay, noninvasive and invasive tests was substantial, yet revascularization was uncommon (2.5%). Multivariate adjustment for age, gender, and baseline cardiovascular risk factors demonstrates similar survival of admitted vs. discharged patients (P = 0.88). Initial hs-cTnT even below the 99th percentile provided a prognostic stratification for long term mortality.
Our findings support a policy of ED discharge of suspected NSTE-ACS patients meeting rapid MI rule-out criteria and subsequent ambulatory evaluation, sparing resource-consuming admissions. In-hospital and ensuing prognosis were better with lower initial hs-cTnT values.
许多疑似非ST段抬高(NSTE)急性冠状动脉综合征(ACS)的患者被收治入院,即使是那些初始高敏心肌肌钙蛋白(hs-cTn)值符合心肌梗死(MI)快速排除标准的患者。我们研究了疑似NSTE-ACS患者的临床结局、资源利用情况及诊断结果,这些患者hs-cTnT值符合上述标准但仍被收治入院。
应用2020年欧洲心脏病学会(ESC)快速排除MI标准,我们确定了连续的患者,其初始hs-cTnT值<5 ng/L或初始值≥5 ng/L但<14 ng/L(第99百分位数)且后续检测中增量较小,但仍被收治入院。大多数(85.4%)因疑似NSTE-ACS就诊于急诊科(ED)的患者初始hs-cTnT<第99百分位数。我们在11477例经分诊并符合MI排除标准的患者中检查了3775例收治患者。仅0.32%(12例)收治患者在30天内发生首次MI或全因死亡。在ED停留时间、住院时间、无创和有创检查方面的资源利用情况较多,但血运重建并不常见(2.5%)。对年龄、性别和基线心血管危险因素进行多变量调整后显示,收治患者与出院患者的生存率相似(P = 0.88)。初始hs-cTnT即使低于第99百分位数也可为长期死亡率提供预后分层。
我们的研究结果支持对符合快速MI排除标准的疑似NSTE-ACS患者采取ED出院并随后进行门诊评估的策略,避免资源消耗大的入院治疗。初始hs-cTnT值较低时,住院期间及后续预后较好。